Colorectal cancer is one of the most preventable cancers we know of — and one of the most undertreated in the screening sense. Roughly one in three adults eligible for screening have never been screened, and the most common reason is the dread of colonoscopy prep. That is understandable, but it is also solvable, because colonoscopy is no longer the only validated option. The goal is a screened colon, not a specific test.
Current Guidelines
The U.S. Preventive Services Task Force recommendation on colorectal cancer screening is the most-cited framework in U.S. primary care:
- Start at age 45 for average-risk adults
- Continue through age 75, with individualized decisions from 76 to 85
- Stop at 85 for most patients
- Earlier screening for African American patients has been supported by specialty groups given earlier onset patterns
The American Cancer Society recommendations align closely, and the CDC's colorectal cancer screening overview offers patient-friendly summaries of each test.
Your Options, in Plain English
1. Colonoscopy — the gold standard
- Cadence: every 10 years for average risk with a normal result
- What it does: direct visualization of the entire colon with ability to remove polyps during the same procedure
- Sensitivity for cancer: ~95%
- Pros: detects and prevents cancer in one step; longest interval
- Cons: full bowel prep, sedation, day off work, small procedural risk
Because it both diagnoses and treats, colonoscopy is the only single-step option — every other test that comes back positive leads to a colonoscopy anyway.
2. FIT (Fecal Immunochemical Test)
- Cadence: annually
- What it does: detects hidden blood in stool using antibodies to human hemoglobin
- Sensitivity for cancer: ~79% (single test)
- Pros: no prep, no sedation, done at home, inexpensive, no dietary restrictions
- Cons: must be repeated every year; positive result requires colonoscopy
FIT is a genuinely good option for average-risk patients who reliably follow through every year.
3. FIT-DNA (Cologuard and similar)
- Cadence: every 3 years
- What it does: combines FIT with DNA markers shed by colorectal cancers and some advanced polyps
- Sensitivity for cancer: ~92%
- Sensitivity for advanced polyps: ~42%
- Pros: home collection, broader interval than FIT, covered by Medicare and most insurers for average-risk adults 45+
- Cons: more false positives than FIT; positive result requires colonoscopy; does not remove polyps
4. CT Colonography ('virtual colonoscopy')
- Cadence: every 5 years
- What it does: low-dose CT imaging of the colon after bowel prep and air insufflation
- Sensitivity for 10 mm+ polyps: ~90%
- Pros: no sedation, faster recovery, visualizes nearby organs
- Cons: same bowel prep; small radiation dose; polyps cannot be removed — a positive study means a follow-up colonoscopy; coverage varies
5. Flexible Sigmoidoscopy
- Cadence: every 5 years, or every 10 years plus annual FIT
- What it does: evaluates only the lower portion of the colon
- Pros: less prep, often no sedation
- Cons: misses right-sided cancers; rarely used in the U.S. today
6. Shield (blood-based screening) — new
- Cadence: every 3 years
- What it does: FDA-approved in 2024, detects circulating tumor DNA and methylation signals in a blood draw
- Sensitivity for cancer: ~83%
- Sensitivity for advanced polyps: ~13% (notably low)
- Pros: simplest possible screen — a blood draw at a routine visit
- Cons: poor detection of polyps, which is how colonoscopy prevents cancer; positive result requires colonoscopy; role still being defined
Shield is an important option for patients who would otherwise decline screening entirely, but it is not equivalent to colonoscopy for prevention.
How to Choose
Who needs colonoscopy (not a stool or blood test)
- Family history of colorectal cancer or advanced polyps in a first-degree relative
- Personal history of colon polyps — see our page on colon polyps for surveillance intervals
- Inflammatory bowel disease, including Crohn's disease and ulcerative colitis — these dramatically change surveillance timelines
- Known or suspected hereditary cancer syndromes (Lynch, FAP)
- Iron-deficiency anemia, unexplained GI bleeding, or concerning change in bowel habits
If you are unsure whether your symptoms are benign IBS or something more serious, our guide IBS vs. IBD: understanding the difference is a good starting point. Our broader article on how your digestive health impacts everything covers why GI symptoms deserve evaluation rather than dismissal.
Who has flexibility
Average-risk patients with no symptoms, no family history, and no prior polyps have real choice. FIT annually, Cologuard every 3 years, CT colonography every 5 years, or Shield every 3 years are all defensible. The best screen is the one you will actually complete on schedule.
The Most Important Rule
A positive stool or blood test is not a diagnosis — it is a signal to complete a colonoscopy within a few weeks. Declining that follow-up erases the benefit of the initial screen. Make sure you understand that before choosing a noninvasive option.
Cost and Coverage
Under the Affordable Care Act, approved colorectal cancer screening tests are covered without cost-sharing for average-risk adults 45-75 in most plans. A recent clarification also mandates coverage of the follow-up colonoscopy after a positive noninvasive screen, though plans and Medicare rules vary. We help patients navigate this at the visit so surprise bills are not a barrier.
Colorectal cancer screening often shows up on our men's health checklist and in every annual physical we perform for patients 45 and older. If you are overdue, or if you are turning 45 this year and unsure where to start, schedule a visit and we will walk through the options together and pick the screen that actually gets done.
